When Antibiotics Fail: The Expert Panel on the Potential Socio-Economic Impacts of Antimicrobial Resistance in Canada
Finlay, Brett B. and Conly, John and Coyte, Peter C. and Dillon, Jo-Anne R. and Douglas, Greg and Goddard, Ellen and Greco, Louisa and Nicolle, Lindsay E. and Patrick, David and Prescott, John F. and Quesnel-Vallee, Amelie and Smith, Richard and Wright, Gerard D. and Harfer, Marco and Taylor, Jirka and Yerushalmi, Erez (2019) When Antibiotics Fail: The Expert Panel on the Potential Socio-Economic Impacts of Antimicrobial Resistance in Canada. Project Report. Council of Canadian Academies, Ottawa, Canada.
Preview |
Text
When-Antibiotics-Fail-1.pdf - Published Version Download (4MB) |
Abstract
Antimicrobials are life savers in Canada, enabling modern healthcare and playing a central role in agriculture. They have reduced the economic, medical, and social burden of infectious diseases and are part of many routine medical interventions, such as caesarean sections, joint replacements, and tonsillectomies.
As use of antimicrobials has increased, bacteria evolved to become resistant, resulting in drugs that are no longer effective at treating infections. Antimicrobial resistance (AMR) is increasing worldwide, and with widespread trade and travel, resistance can spread quickly, posing a serious threat to all countries. For Canada, the implications of AMR are stark.
When Antibiotics Fail examines the current impacts of AMR on our healthcare system, projects the future impact on Canada’s GDP, and looks at how widespread resistance will influence the day-to-day lives of Canadians. The report examines these issues through a One Health lens, recognizing the interconnected nature of AMR, from healthcare settings to the environment to the agriculture sector. It is the most comprehensive report to date on the economic impact of AMR in Canada.
Actions (login required)
 |
View Item |
Tools
Tools
